ProCE Banner Activity

Planning First-line Treatment for Favorable-Risk Patients With Advanced RCC

Slideset

Download this slideset from M. Dror Michaelson, MD, PhD, on his perspective for the optimal use of systemic therapy in the first-line setting for favorable-risk patients with advanced RCC.

Released: February 13, 2020

Expiration: February 11, 2021

Share

Faculty

Brian A. Costello

Brian A. Costello, MD, MS

Associate Professor of Oncology and Urology
Consultant

Division of Medical Oncology
Mayo Clinic
Rochester, Minnesota

Provided by

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from
Eisai
Pfizer and EMD Serono

Supported by a medical education grant from
Exelixis, Inc.
Supported by an independent educational grant from

Merck Oncology

Partners

Clinical Care Options, LLC

ProCE Banner

Faculty Disclosure

Primary Author

Brian A. Costello, MD, MS

Associate Professor of Oncology and Urology
Consultant

Division of Medical Oncology
Mayo Clinic
Rochester, Minnesota